| Dr Devin Lochlan Mccaslin, PHD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Dr Devin Lochlan Mccaslin |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 25 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114178829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1601001011 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.
Noting that the "roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.
This November, facial hair is taking the month by storm with men sprouting 'staches and beards to support their fellow man. For the third consecutive year, ZERO's Grow & Give campaign is dedicated exclusively to raising awareness and funds to fight prostate cancer, a disease that kills an American man every 20 minutes.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
Millions of children fail to reach their developmental potential worldwide, in part due to higher rates of exposure to current and legacy pollutants.
› Verified 8 days ago
| Provider Name | Regents Of The University Of Michigan |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326307489 PECOS PAC ID: 3779496856 Enrollment ID: O20031117000199 |
News Archive
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.
Noting that the "roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.
This November, facial hair is taking the month by storm with men sprouting 'staches and beards to support their fellow man. For the third consecutive year, ZERO's Grow & Give campaign is dedicated exclusively to raising awareness and funds to fight prostate cancer, a disease that kills an American man every 20 minutes.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
Millions of children fail to reach their developmental potential worldwide, in part due to higher rates of exposure to current and legacy pollutants.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Devin Lochlan Mccaslin, PHD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Dr Devin Lochlan Mccaslin, PHD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.
Noting that the "roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.
This November, facial hair is taking the month by storm with men sprouting 'staches and beards to support their fellow man. For the third consecutive year, ZERO's Grow & Give campaign is dedicated exclusively to raising awareness and funds to fight prostate cancer, a disease that kills an American man every 20 minutes.
The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials.
Millions of children fail to reach their developmental potential worldwide, in part due to higher rates of exposure to current and legacy pollutants.
› Verified 8 days ago
Diane Donmyer Carter, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 203 S Zeeb Rd, Suite 207, Ann Arbor, MI 48103 Phone: 734-994-8300 Fax: 734-994-8353 | |
Regents Of The University Of Michigan Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4260 Plymouth Rd, Ann Arbor, MI 48109 Phone: 734-647-6591 | |
Miss Leanne Marie Hoover, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Audiology (126), Ann Arbor, MI 48105 Phone: 734-769-7100 Fax: 734-761-7304 | |
Megan Miller Cherry, AUD. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 1st Floor Taubman Ctr Recp A, Ann Arbor, MI 48109 Phone: 734-936-8051 | |
Ms. Kimberly A Land, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Audiology, 126, Ann Arbor, MI 48105 Phone: 734-769-7100 | |
Mrs. Sara Joanne Hieber, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 203 S. Zebb Rd., Suite 207, Ann Arbor, MI 48103 Phone: 734-994-8300 Fax: 734-994-8353 | |
Dr. Howard B Calder, PHD. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 812 Avis Dr, Ann Arbor, MI 48108 Phone: 734-677-0056 |